表紙
市場調查報告書

牙痛:開發中產品分析

Dental Pain - Pipeline Review, H2 2019

出版商 Global Markets Direct 商品編碼 408072
出版日期 內容資訊 英文 42 Pages
訂單完成後即時交付
價格
Back to Top
牙痛:開發中產品分析 Dental Pain - Pipeline Review, H2 2019
出版日期: 2019年12月02日內容資訊: 英文 42 Pages
簡介

本報告提供以牙痛的治療藥開發平台現狀及最新更新的各開發階段比較分析,提供您加上最新的新聞和發表之企業和研究機關開發中的治療藥,治療藥評估,後期階段及中止的計劃等相關資訊。

簡介

  • 調查範圍

牙痛 概要

治療藥的開發

  • 開發中產品;概要

企業開發中的治療藥

開發中產品概況

  • 後期階段的產品
  • 臨床實驗階段的產品
  • 初期階段的產品

企業開發中的產品

開發治療藥的企業

  • Boehringer Ingelheim GmbH
  • Laboratorios Del Dr Esteve SA
  • Pacira Pharmaceuticals Inc
  • Teva Pharmaceutical Industries Ltd

治療藥的評估

  • 單劑產品
  • 組合產品
  • 標的別
  • 各作用機制
  • 各給藥途徑
  • 各分子類型

藥物簡介

暫停中的計劃

開發中止的產品

產品開發的里程碑

  • 主要消息和新聞稿

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC11598IDB

Summary:

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Dental Pain - Pipeline Review, H2 2019, provides an overview of the Dental Pain (Central Nervous System) pipeline landscape.

A pain in the tooth is called dental pain. This can be caused by tooth decay, damaged filling, tooth fracture, etc. Symptoms of a toothache may include: tooth pain that may be sharp, throbbing, or constant. In some people, pain results only when pressure is applied to the tooth. Swelling around the tooth, fever or headache and foul-tasting drainage from the infected tooth occurs. Treatment for a toothache depends on the cause.

Report Highlights:

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Dental Pain - Pipeline Review, H2 2019, provides comprehensive information on the therapeutics under development for Dental Pain (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Dental Pain (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Dental Pain (Toothache/Tooth Pain) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II and Discovery stages are 1, 2, 2 and 1 respectively.

Dental Pain (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope:

  • The pipeline guide provides a snapshot of the global therapeutic landscape of Dental Pain (Central Nervous System).
  • The pipeline guide reviews pipeline therapeutics for Dental Pain (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.
  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
  • The pipeline guide reviews key companies involved in Dental Pain (Central Nervous System) therapeutics and enlists all their major and minor projects.
  • The pipeline guide evaluates Dental Pain (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
  • The pipeline guide reviews latest news related to pipeline therapeutics for Dental Pain (Central Nervous System)

Reasons to buy:

  • Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
  • Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
  • Find and recognize significant and varied types of therapeutics under development for Dental Pain (Central Nervous System).
  • Classify potential new clients or partners in the target demographic.
  • Develop tactical initiatives by understanding the focus areas of leading companies.
  • Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.
  • Formulate corrective measures for pipeline projects by understanding Dental Pain (Central Nervous System) pipeline depth and focus of Indication therapeutics.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
  • Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Contents

  • List of Tables
  • List of Figures
  • Introduction
    • Global Markets Direct Report Coverage
  • Dental Pain (Toothache/Tooth Pain) - Overview
  • Dental Pain (Toothache/Tooth Pain) - Therapeutics Development
    • Pipeline Overview
    • Pipeline by Companies
    • Products under Development by Companies
  • Dental Pain (Toothache/Tooth Pain) - Therapeutics Assessment
    • Assessment by Target
    • Assessment by Mechanism of Action
    • Assessment by Route of Administration
    • Assessment by Molecule Type
  • Dental Pain (Toothache/Tooth Pain) - Companies Involved in Therapeutics Development
    • AfaSci Inc
    • Esteve Pharmaceuticals SA
    • Grunenthal GmbH
    • Nevakar Inc
    • Pacira BioSciences Inc
    • Promius Pharma LLC
  • Dental Pain (Toothache/Tooth Pain) - Drug Profiles
    • (celecoxib + tramadol hydrochloride) - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • (diclofenac sodium + tramadol hydrochloride) - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • acetaminophen - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • AFAP-3 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • bupivacaine ER - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • DFN-15 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
  • Dental Pain (Toothache/Tooth Pain) - Dormant Projects
  • Dental Pain (Toothache/Tooth Pain) - Discontinued Products
  • Dental Pain (Toothache/Tooth Pain) - Product Development Milestones
    • Featured News & Press Releases
      • Jun 26, 2019: New retrospective analysis shows EXPAREL associated with significantly less opioid use following third molar extraction
      • Sep 13, 2017: Pacira Pharmaceuticals, Aetna, and the American Association of Oral and Maxillofacial Surgeons join together in a program to reduce opioid exposure for patients undergoing wisdom tooth extraction
      • Jun 21, 2012: Iroko Pharma Announces Phase III Study Results Of Diclofenac
      • Nov 04, 2011: Phase II Results For Nano-formulated NSAIDs Under Development At Iroko Pharmaceuticals To Be Reported At ACR Meeting
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Number of Products under Development for Dental Pain (Toothache/Tooth Pain), H2 2019
  • Number of Products under Development by Companies, H2 2019
  • Products under Development by Companies, H2 2019
  • Number of Products by Stage and Target, H2 2019
  • Number of Products by Stage and Mechanism of Action, H2 2019
  • Number of Products by Stage and Route of Administration, H2 2019
  • Number of Products by Stage and Molecule Type, H2 2019
  • Dental Pain (Toothache/Tooth Pain) - Pipeline by AfaSci Inc, H2 2019
  • Dental Pain (Toothache/Tooth Pain) - Pipeline by Esteve Pharmaceuticals SA, H2 2019
  • Dental Pain (Toothache/Tooth Pain) - Pipeline by Grunenthal GmbH, H2 2019
  • Dental Pain (Toothache/Tooth Pain) - Pipeline by Nevakar Inc, H2 2019
  • Dental Pain (Toothache/Tooth Pain) - Pipeline by Pacira BioSciences Inc, H2 2019
  • Dental Pain (Toothache/Tooth Pain) - Pipeline by Promius Pharma LLC, H2 2019
  • Dental Pain (Toothache/Tooth Pain) - Dormant Projects, H2 2019
  • Dental Pain (Toothache/Tooth Pain) - Dormant Projects, H2 2019 (Contd..1), H2 2019
  • Dental Pain (Toothache/Tooth Pain) - Discontinued Products, H2 2019

List of Figures

  • Number of Products under Development for Dental Pain (Toothache/Tooth Pain), H2 2019
  • Number of Products under Development by Companies, H2 2019
  • Number of Products by Top 10 Targets, H2 2019
  • Number of Products by Stage and Top 10 Targets, H2 2019
  • Number of Products by Top 10 Mechanism of Actions, H2 2019
  • Number of Products by Stage and Top 10 Mechanism of Actions, H2 2019
  • Number of Products by Routes of Administration, H2 2019
  • Number of Products by Stage and Routes of Administration, H2 2019
  • Number of Products by Molecule Types, H2 2019
  • Number of Products by Stage and Molecule Types, H2 2019
Back to Top